Skip to main content

Developmental Therapeutics Program News

Our team members have made game-changing breakthroughs in cancer research and drug development.

Existing patients or family members
New patients, referrals and second opinions

In the Journals: Nirsevimab

Jan 18, 2024

Find out about the results of a prospective, placebo-controlled trial in 8,058 healthy infants that served as the basis for licensure of nirsevimab.

Jump back to top